newdrugapprovals.org
Teva’s Asthma Drug ‘Significantly’ Improves Lung Function In Phase 3 Trials
// Reslizumab CAS 241473-69-8 PETAH TIKVA (dpa-AFX) – Teva Pharmaceutical Industries Ltd. (TEVA) Monday said asthma patients with elevated eosinophils showed significant improvement in lung …